z-logo
open-access-imgOpen Access
What the future holds for gliptins
Author(s) -
Radhika Jindal,
Ayesha Ahmad,
Mahmudur Rahman Siddiqui,
Subhash Kumar Wangnoo
Publication year - 2012
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.104050
Subject(s) - medicine , glycemic , pancreas , diabetes mellitus , pancreatic cancer , pancreatitis , endocrinology , cancer
Gliptins have revolutionised the treatment of Type 2 Diabetes Mellitus, addressing the hyperglycemia through its effects on the alpha and beta cells of the pancreas. In this article,we review the extra-glycemic effects of gliptins on central nervous system, cardiovascular biology and the bone health and concerns regarding pancreatitis and pancreatic cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here